(TPR) Tapestry - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US8760301072
Stock:
Total Rating 72
Risk 64
Buy Signal 2.13
| Risk 5d forecast | |
|---|---|
| Volatility | 35.4% |
| Relative Tail Risk | -10.9% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.62 |
| Alpha | 69.49 |
| Character TTM | |
|---|---|
| Beta | 1.152 |
| Beta Downside | 1.965 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.54% |
| CAGR/Max DD | 1.48 |
EPS (Earnings per Share)
Revenue
Description: TPR Tapestry
Tapestry, Inc. provides accessories and lifestyle brand products in North America, Greater China, rest of Asia, and internationally. The company operates in three segments: Coach, Kate Spade, and Stuart Weitzman. It offers women's handbags, fashion designs, business cases, computer bags, messenger style bags, backpacks, travel bags, and totes; and accessories, such as small leather goods which includes mini and micro handbags, money pieces, wristlets, pouches, and cosmetic cases, as well as novelty accessories, including address books, time management and travel accessories, sketchbooks, and portfolios; and belts, key rings, technology accessories, gifting, straps, and charms. The company also provides women's and men's footwear, which casual and dress shoes, boots, sneakers, and sandals; and other products which includes outerwear, ready-to-wear, jewelry, watches, eyewear, fragrance, scarves, hats, gloves, and other products. It offers its products through retail and outlet stores, brand e-commerce sites, and concession shop-in-shops under the Coach, Kate Spade, and Stuart Weitzman brand names. The company was formerly known as Coach, Inc. and changed its name to Tapestry, Inc. in October 2017. Tapestry, Inc. was founded in 1941 and is headquartered in New York, New York.
Piotroski VR‑10 (Strict, 0-10) 8.5
| Net Income: 522.3m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA 13.93 > 1.0 |
| NWC/Revenue: 14.29% < 20% (prev 15.07%; Δ -0.77% < -1%) |
| CFO/TA 0.27 > 3% & CFO 1.78b > Net Income 522.3m |
| Net Debt (4.12b) to EBITDA (938.8m): 4.39 < 3 |
| Current Ratio: 1.63 > 1.5 & < 3 |
| Outstanding Shares: last quarter (209.8m) vs 12m ago -6.71% < -2% |
| Gross Margin: 75.98% > 18% (prev 0.75%; Δ 7523 % > 0.5%) |
| Asset Turnover: 109.0% > 50% (prev 93.44%; Δ 15.60% > 0%) |
| Interest Coverage Ratio: 12.12 > 6 (EBITDA TTM 938.8m / Interest Expense TTM 60.4m) |
Altman Z'' -0.46
| A: 0.16 (Total Current Assets 2.79b - Total Current Liabilities 1.72b) / Total Assets 6.53b |
| B: -0.50 (Retained Earnings -3.29b / Total Assets 6.53b) |
| C: 0.11 (EBIT TTM 732.0m / Avg Total Assets 6.89b) |
| D: -0.58 (Book Value of Equity -3.49b / Total Liabilities 5.98b) |
| Altman-Z'' Score: -0.46 = B |
Beneish M -3.38
| DSRI: 0.91 (Receivables 569.5m/564.6m, Revenue 7.51b/6.78b) |
| GMI: 0.98 (GM 75.98% / 74.77%) |
| AQI: 0.75 (AQ_t 0.29 / AQ_t-1 0.38) |
| SGI: 1.11 (Revenue 7.51b / 6.78b) |
| TATA: -0.19 (NI 522.3m - CFO 1.78b) / TA 6.53b) |
| Beneish M-Score: -3.38 (Cap -4..+1) = AA |
What is the price of TPR shares?
As of February 26, 2026, the stock is trading at USD 156.92 with a total of 2,293,412 shares traded.
Over the past week, the price has changed by +1.24%, over one month by +24.36%, over three months by +46.24% and over the past year by +89.76%.
Over the past week, the price has changed by +1.24%, over one month by +24.36%, over three months by +46.24% and over the past year by +89.76%.
Is TPR a buy, sell or hold?
Tapestry has received a consensus analysts rating of 4.14.
Therefore, it is recommended to buy TPR.
- StrongBuy: 10
- Buy: 5
- Hold: 5
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the TPR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 159.7 | 1.8% |
| Analysts Target Price | 159.7 | 1.8% |
TPR Fundamental Data Overview February 24, 2026
P/E Trailing = 60.8876
P/E Forward = 21.1864
P/S = 4.278
P/B = 27.8871
P/EG = 0.3711
Revenue TTM = 7.51b USD
EBIT TTM = 732.0m USD
EBITDA TTM = 938.8m USD
Long Term Debt = 2.38b USD (from longTermDebt, last quarter)
Short Term Debt = 331.0m USD (from shortTermDebt, last quarter)
Debt = 5.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.12b USD (from netDebt column, last quarter)
Enterprise Value = 36.27b USD (32.15b + Debt 5.18b - CCE 1.05b)
Interest Coverage Ratio = 12.12 (Ebit TTM 732.0m / Interest Expense TTM 60.4m)
EV/FCF = 21.57x (Enterprise Value 36.27b / FCF TTM 1.68b)
FCF Yield = 4.64% (FCF TTM 1.68b / Enterprise Value 36.27b)
FCF Margin = 22.38% (FCF TTM 1.68b / Revenue TTM 7.51b)
Net Margin = 6.95% (Net Income TTM 522.3m / Revenue TTM 7.51b)
Gross Margin = 75.98% ((Revenue TTM 7.51b - Cost of Revenue TTM 1.80b) / Revenue TTM)
Gross Margin QoQ = 75.46% (prev 76.29%)
Tobins Q-Ratio = 5.55 (Enterprise Value 36.27b / Total Assets 6.53b)
Interest Expense / Debt = 0.34% (Interest Expense 17.4m / Debt 5.18b)
Taxrate = 19.48% (135.8m / 697.1m)
NOPAT = 589.4m (EBIT 732.0m * (1 - 19.48%))
Current Ratio = 1.63 (Total Current Assets 2.79b / Total Current Liabilities 1.72b)
Debt / Equity = 9.39 (Debt 5.18b / totalStockholderEquity, last quarter 551.2m)
Debt / EBITDA = 4.39 (Net Debt 4.12b / EBITDA 938.8m)
Debt / FCF = 2.45 (Net Debt 4.12b / FCF TTM 1.68b)
Total Stockholder Equity = 825.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.58% (Net Income 522.3m / Total Assets 6.53b)
RoE = 63.26% (Net Income TTM 522.3m / Total Stockholder Equity 825.6m)
RoCE = 22.84% (EBIT 732.0m / Capital Employed (Equity 825.6m + L.T.Debt 2.38b))
RoIC = 17.56% (NOPAT 589.4m / Invested Capital 3.36b)
WACC = 8.79% (E(32.15b)/V(37.33b) * Re(10.16%) + D(5.18b)/V(37.33b) * Rd(0.34%) * (1-Tc(0.19)))
Discount Rate = 10.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.84%
[DCF] Terminal Value 76.44% ; FCFF base≈1.35b ; Y1≈1.46b ; Y5≈1.80b
[DCF] Fair Price = 113.0 (EV 26.99b - Net Debt 4.12b = Equity 22.87b / Shares 202.5m; r=8.79% [WACC]; 5y FCF grow 8.95% → 2.90% )
EPS Correlation: 66.78 | EPS CAGR: 55.81% | SUE: 4.0 | # QB: 2
Revenue Correlation: 43.85 | Revenue CAGR: 15.93% | SUE: 4.0 | # QB: 6
EPS next Quarter (2026-03-31): EPS=1.28 | Chg7d=-0.001 | Chg30d=+0.272 | Revisions Net=+14 | Analysts=19
EPS current Year (2026-06-30): EPS=6.50 | Chg7d=+0.086 | Chg30d=+0.861 | Revisions Net=+16 | Growth EPS=+27.4% | Growth Revenue=+11.4%
EPS next Year (2027-06-30): EPS=7.19 | Chg7d=+0.146 | Chg30d=+0.920 | Revisions Net=+15 | Growth EPS=+10.6% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: +1.00 (14 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.5% (Discount Rate 10.2% - Earnings Yield 1.6%)
[Growth] Growth Spread = +3.4% (Analyst 11.9% - Implied 8.5%)
P/E Forward = 21.1864
P/S = 4.278
P/B = 27.8871
P/EG = 0.3711
Revenue TTM = 7.51b USD
EBIT TTM = 732.0m USD
EBITDA TTM = 938.8m USD
Long Term Debt = 2.38b USD (from longTermDebt, last quarter)
Short Term Debt = 331.0m USD (from shortTermDebt, last quarter)
Debt = 5.18b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.12b USD (from netDebt column, last quarter)
Enterprise Value = 36.27b USD (32.15b + Debt 5.18b - CCE 1.05b)
Interest Coverage Ratio = 12.12 (Ebit TTM 732.0m / Interest Expense TTM 60.4m)
EV/FCF = 21.57x (Enterprise Value 36.27b / FCF TTM 1.68b)
FCF Yield = 4.64% (FCF TTM 1.68b / Enterprise Value 36.27b)
FCF Margin = 22.38% (FCF TTM 1.68b / Revenue TTM 7.51b)
Net Margin = 6.95% (Net Income TTM 522.3m / Revenue TTM 7.51b)
Gross Margin = 75.98% ((Revenue TTM 7.51b - Cost of Revenue TTM 1.80b) / Revenue TTM)
Gross Margin QoQ = 75.46% (prev 76.29%)
Tobins Q-Ratio = 5.55 (Enterprise Value 36.27b / Total Assets 6.53b)
Interest Expense / Debt = 0.34% (Interest Expense 17.4m / Debt 5.18b)
Taxrate = 19.48% (135.8m / 697.1m)
NOPAT = 589.4m (EBIT 732.0m * (1 - 19.48%))
Current Ratio = 1.63 (Total Current Assets 2.79b / Total Current Liabilities 1.72b)
Debt / Equity = 9.39 (Debt 5.18b / totalStockholderEquity, last quarter 551.2m)
Debt / EBITDA = 4.39 (Net Debt 4.12b / EBITDA 938.8m)
Debt / FCF = 2.45 (Net Debt 4.12b / FCF TTM 1.68b)
Total Stockholder Equity = 825.6m (last 4 quarters mean from totalStockholderEquity)
RoA = 7.58% (Net Income 522.3m / Total Assets 6.53b)
RoE = 63.26% (Net Income TTM 522.3m / Total Stockholder Equity 825.6m)
RoCE = 22.84% (EBIT 732.0m / Capital Employed (Equity 825.6m + L.T.Debt 2.38b))
RoIC = 17.56% (NOPAT 589.4m / Invested Capital 3.36b)
WACC = 8.79% (E(32.15b)/V(37.33b) * Re(10.16%) + D(5.18b)/V(37.33b) * Rd(0.34%) * (1-Tc(0.19)))
Discount Rate = 10.16% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.84%
[DCF] Terminal Value 76.44% ; FCFF base≈1.35b ; Y1≈1.46b ; Y5≈1.80b
[DCF] Fair Price = 113.0 (EV 26.99b - Net Debt 4.12b = Equity 22.87b / Shares 202.5m; r=8.79% [WACC]; 5y FCF grow 8.95% → 2.90% )
EPS Correlation: 66.78 | EPS CAGR: 55.81% | SUE: 4.0 | # QB: 2
Revenue Correlation: 43.85 | Revenue CAGR: 15.93% | SUE: 4.0 | # QB: 6
EPS next Quarter (2026-03-31): EPS=1.28 | Chg7d=-0.001 | Chg30d=+0.272 | Revisions Net=+14 | Analysts=19
EPS current Year (2026-06-30): EPS=6.50 | Chg7d=+0.086 | Chg30d=+0.861 | Revisions Net=+16 | Growth EPS=+27.4% | Growth Revenue=+11.4%
EPS next Year (2027-06-30): EPS=7.19 | Chg7d=+0.146 | Chg30d=+0.920 | Revisions Net=+15 | Growth EPS=+10.6% | Growth Revenue=+5.4%
[Analyst] Revisions Ratio: +1.00 (14 Up / 0 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 8.5% (Discount Rate 10.2% - Earnings Yield 1.6%)
[Growth] Growth Spread = +3.4% (Analyst 11.9% - Implied 8.5%)